Our Research
-
Towards clinical translation
Having been awarded a 3-year Trish Translational Research Project Grant titled, “Advancing tolerogenic dendritic cell therapy for multiple sclerosis toward clinical translation” which commenced January 2023, Professor Trevor Kilpatrick and Dr Vivien Li are making significant progress. They are working on a new way to treat MS, based on using patients’ own blood immune cells. …
-
Preventing disability in aggressive MS
Commencing January 2020, Associate Professor Anneke Van der Walt, Monash University was awarded a Trish Translational Research Grant over three years funded by the Trish MS Research Foundation. A/Prof Van der Walt’s research is titled, “Active Participatory Health Monitoring in people with Multiple Sclerosis (Active-MS)”. Co-Investigators are Professor Helmut Butzkueven, Dr Vilija Jokubaitis, Dr Scott Kolbe,…
-
Potential “best-in-class” therapeutics
Commencing January 2020, Dr Steven Petratos, Monash University, was awarded a 3-year Trish Translational Research Project Grant titled, “Developing a new drug to repair the brain in Multiple Sclerosis”. Dr Petratos and his team have been looking to repurpose a drug previously approved for use in a different neurological condition. He had previously shown that…
-
Cellular therapy
Commencing January 2020, Professor Trevor Kilpatrick, University of Melbourne, was awarded a 3-year Trish Translational Project Grant titled, “Developing cellular therapy to treat multiple sclerosis”. The funds were used in a project to develop a therapy for multiple sclerosis (MS) based on using immune cells from the blood of patients with MS. These immune cells…
-
NHMRC ‘top up’ funding
Commencing January 2020, Dr Vivien Li, The Florey Institute of Neuroscience and Mental Health Victoria, was awarded a Postgraduate Research Scholarship over three years funded by the National Health & Medical Research Council with ‘top up’ funding provided by the Trish MS Research Foundation. The aim of the Project titled, “Towards developing dendritic cell therapy…
-
Key Advances
In 2019 Dr Justin Garber, the University of Sydney, was awarded a Trish MS Research Foundation Postgraduate Scholarship titled “Using MRI to measure MS severity and progression”. Due to being appointed to a Staff Specialist Neurologist position at Westmead Hospital, as Director of the MS Clinic, Dr Garber completed the final year of his Postgraduate…
-
Research leading to a $1.1M NHMRC Ideas Grant
Commencing January 2019, Dr Junhua Xiao, the University of Melbourne, was awarded a 3-year Project Grant titled “How neurons regulate cortical and subcortical remyelination”. Dr Xiao subsequently left the University and her Project Grant was awarded to A/Prof Simon Murray who has continued her important work. In this research the scientists have been looking at…
-
Active Participatory Health Monitoring
Commencing January 2020, A/Prof Anneke van der Walt was awarded a three-year Trish Translational Research Project Grant titled, “Active Participatory Health Monitoring in people with Multiple Sclerosis (Active-MS)”. The aim of the Project is to implement and validate novel tests that can be used to predict, early on, if patients with MS are likely to…
-
The vitamin D response pathway
The Trish Foundation is currently funding Dr Grant Parnell’s research titled, “Defining how vitamin D promotes tolerogenic dendritic cells to enable its use in combined therapy”. The research is being carried out at The Westmead Institute for Medical Research / The University of Sydney. The aim of this project is to better understand the vitamin…
-
Excellent progress
Commencing January 2022, Dr Izanne Roos, University of Melbourne was granted a 3-year Trish Translational Research Project Grant titled, “Personalised therapy to prevent disability in aggressive multiple sclerosis”. Dr Roos’ diligent, very hard work is enabling excellent progress to be achieved. In this research project, Dr Roos and her team are aiming to validate statistical…